Category: Uncategorized

The decision made with regard to NICE 30 day TA916 for Bimekizumab for treating active psoriatic arthritis can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA920 & TA927: Tofacitinib for active Ankylosing Spondylitis & Glofitamab for B-cell lymphoma, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Thursday 2nd November 2023. Take part by visiting the consultations page.

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA918: Bimekizumab for treating axial spondyloarthritis, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 25th October 2023. Take part by visiting the consultations page.

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on two new consultations:

• adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in September 2023
• draft decisions made by the NENC formulary group at their meeting in September 2023

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC. These consultations will run for four weeks and close at 5pm on Tuesday 7th November 2023. Take part by visiting the consultations page.

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA916: Bimekizumab for treating active psoriatic arthritis, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 18th October 2023. Take part by visiting the consultations page.

The decisions made at the NENC Medicines Subcommittee September 2023 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

This includes the recommendations made by NTAG in July 2023 meeting and NICE Technology appraisals from the 1st April 2023 to 31st May 2023.

The following guidelines/position statements were approved and can be found at:

• NENC Continuous glucose monitoring including FreeStyle Libre 2 and Dexcom One https://ntag.nhs.uk/recommendations/endocrine-system-recommendations/

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in August 2023.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Tuesday 10th October 2023. Take part by visiting the consultations page.

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 6th September 2023. Take part by visiting the consultations page.

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the draft decisions made by the NENC formulary group at their meeting in July 2023.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

The consultation is open until 5pm on Tuesday 22^nd August 2023 and can be accessed on the consultations page.

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Monday 7th August 2023. Take part by visiting the consultations page.